Use of 5-iodo-2-deoxyuridine (Idoxuridine) in cutaneous herpes simplex.

Twelve patients with cutaneous herpes simplex were treated in a double blind series with either 0.1 per cent idoxuridine solution or a placebo. There was no significant difference in healing time between those receiving the drug and those the placebo. The same conclusion was noted in a series of eleven patients using either 1 per cent idoxuridine in a cream or a placebo.

RCT Entities:   Population Interventions Outcomes